Pharmaceutical combination and use thereof
US-2024189341-A1 · Jun 13, 2024 · US
Influenza vaccine, composition, and methods of use
US9526778B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9526778-B2 |
| Application number | US-200913377070-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 15, 2009 |
| Priority date | Jun 15, 2009 |
| Publication date | Dec 27, 2016 |
| Grant date | Dec 27, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The invention relates to compositions and vaccines that include a mutated Bordetella strain for treating or preventing an influenza infection in a mammal. In addition, the invention further provides methods for protecting a mammal against infection by influenza and/or eliciting an immune response against an influenza virus in a mammal using the composition or vaccine.
First claim
Opening claim text (preview).
What is claimed: 1. A method of lessening the severity of lung immunopathology due to infection with influenza A virus in a mammalian subject who is at increased risk of developing the infection, said method comprising the step of administering to the subject a sufficient amount of a live attenuated, mutated Bordetella pertussis strain, wherein the strain comprises a mutated pertussis toxin(ptx) gene, a deleted or mutated dermonecrotic (dnt) gene, and a heterologous ampG gene, an…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
- A61K39/099Primary
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9526778B2 cover?
- The invention relates to compositions and vaccines that include a mutated Bordetella strain for treating or preventing an influenza infection in a mammal. In addition, the invention further provides methods for protecting a mammal against infection by influenza and/or eliciting an immune response against an influenza virus in a mammal using the composition or vaccine.
- Who is the assignee on this patent?
- Alonso Sylvie, Li Rui, Chow Vincent, and 4 more
- What technology area does this patent fall under?
- Primary CPC classification A61K39/099. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).